Your browser doesn't support javascript.
loading
Single-dose cefixime 800 mg plus doxycycline 100 mg twice a day for 7 days compared with single-dose ceftriaxone 1 g plus single-dose azithromycin 2 g for treatment of urogenital, rectal, and pharyngeal gonorrhoea: a randomised clinical trial.
Bízová, Beatrice; Procházka, Premysl; Nycová, Elka; Boril, Petr; Kubele, Jan; Poláková, Anna; Zemanová, Zuzana; Unemo, Magnus; Rob, Filip.
Afiliação
  • Bízová B; Dermatovenereology Department, Second Faculty of Medicine, Charles University, University Hospital Bulovka, Prague, Czech Republic.
  • Procházka P; Venereology Prague, Medicentrum Beroun, Prague, Czech Republic.
  • Nycová E; Department of Microbiology, University Hospital Bulovka, Prague, Czech Republic.
  • Boril P; Clinical Laboratory, Medicentrum Beroun, Beroun, Czech Republic.
  • Kubele J; Clinical Microbiology and ATB Centre, Na Homolce Hospital, Prague, Czech Republic.
  • Poláková A; Department of Microbiology, University Hospital Bulovka, Prague, Czech Republic.
  • Zemanová Z; Clinical Microbiology and ATB Centre, Na Homolce Hospital, Prague, Czech Republic.
  • Unemo M; World Health Organization Collaborating Centre for Gonorrhoea and Other STIs, Department of Laboratory Medicine, Microbiology, Faculty of Medicine of Health, Örebro University, Örebro, Sweden; Institute for Global Health, University College London, London, United Kingdom.
  • Rob F; Dermatovenereology Department, Second Faculty of Medicine, Charles University, University Hospital Bulovka, Prague, Czech Republic. Electronic address: filip.rob@bulovka.cz.
Clin Microbiol Infect ; 30(2): 211-215, 2024 Feb.
Article em En | MEDLINE | ID: mdl-37981059

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ceftriaxona / Gonorreia Limite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ceftriaxona / Gonorreia Limite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article